Ischemic Stroke clinical trials
80 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Relying on Pharmacotherapy to Improve Motor Gains in Chronic Stroke Survivors
- Verapamil for Neuroprotection in Stroke
- Motor Recovery Through Plasticity-Inducing Cortical Stimulation
- Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability
- Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe
- Minocycline in Stroke Study at Maimonides
- Pilot/Pivotal Study of DBS+Rehab After Stroke
- Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial
- Promoting Recovery After STroke With Amantadine
- Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
- Strategy for Improving Stroke Treatment Response
- Hand and Arm Motor Recovery Via Non-invasive Electrical Spinal Cord Stimulation After Stroke
- Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
- Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
- K01 Impacts of Lingual Endurance Exercise
- The Recovery in Stroke Using PAP Study
- NobleStitch EL STITCH Trial is a PFO Comparative Trial
- A Study Of Vagus Nerve Stimulation (VNS) With Mobility Training For Gait Recovery After Chronic Ischemic Stroke
- StrokeNet Thrombectomy Endovascular Platform
- Virtual Reality Based Rehabilitation After Ischemic Stroke
- kTMP-Enhanced Motor Rehabilitation for Chronic Stroke Recovery (KULMINATE) Pilot
- Improving Visual Field Deficits With Noninvasive Brain Stimulation
- Autologous Mitochondrial Transplant for Cerebral Ischemia
- Brain Stimulation Effects on Post-Stroke Fatigue and Aphasia
- Utility of CC7 Transfer in Stroke Subtypes
- Personalized Transcranial Direct Current Stimulation in Stroke Recovery
- Cognitive Strategies for Optimizing Brain Health And Managing Transgenerational Vascular Risk Factors Post-Stroke
- SDOH-Homecare Intervention Focus Team (SHIFT) Trial to Improve Stroke Outcomes
- External Post-Operative Skull Prosthesis to Prevent Sunken Flap Syndrome in Craniectomy Patients
- Non-standardized vs. Standardized Screening for Dysphagia
- RIsE Stroke Mobility Study
- Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation
- Continuous Dual Aspiration Technique With Zoom System for Stroke
- Michigan Initial Experience Using Tigertriever for Thrombectomy
- Image Detection of Impaired Microcirculatory Reperfusion
- Post-Stroke Sensory Reweighting on Walking and Balance Outcomes
- Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke
- Somatic Dysfunction in Patients With Acute Cerebrovascular Disease
- Implementation of Onsite Rapid CYP2C19 Assay for Genotype Guided Dual Antiplatelet Therapy After Acute Ischemic Stroke
- Long-Term Outcomes of LAA Contrast Flow in CT Scans After Endocardial LAA Closure: The CF-CT Registry
- Treatment With Endovascular Intervention for STroke Patients With Existing Disability
- DELTA (Detecting and Predicting Atrial Fibrillation in Post-Stroke Patients)
- Blood Pressure Variability and Ischemic Stroke Outcome
- Vagal Nerve Stimulation in Enhanced Stroke Recovery: The VALOR Registry
- Global Blood-Brain Barrier Disruption and Post-Stroke Cognitive Decline
- Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
- Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
- Vivistim Registry for Paired VNS Therapy (GRASP)
- Feasibility of a Remotely Delivered Step Count Intervention in Chronic Stroke
- Left Atrial Strain and Cryptogenic Stroke
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Ischemic Stroke” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.